← Back to Clinical Trials
Recruiting NCT06671925

NCT06671925 A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06671925
Status Recruiting
Phase —
Sponsor Weill Medical College of Cornell University
Condition Chronic Pain
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-01-27
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Strengthening COnnections to Overcome Pain (SCOOP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-01-27 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test a new community health worker-delivered program (Strengthening COnnections to Overcome Pain, or SCOOP) that teaches strategies for managing chronic pain and loneliness to older adults living in rural areas. The main questions it aims to answer are: 1. Does participating in SCOOP result in less pain interference with daily life? 2. Does participating in SCOOP result in decreased loneliness? 3. What is the level of participant engagement in SCOOP? Researchers will compare people who have participated in SCOOP with people who have not participated in SCOOP to see if SCOOP is helpful in decreasing pain interference and loneliness. Participants will: 1. Watch brief videos teaching strategies to manage pain and boost social connections. 2. Engage in up to 7 weekly coaching sessions with a community health worker. 3. Complete two telephone interviews about health, mental health, and functioning: one at baseline, and one 2 months later.

Eligibility Criteria

Inclusion Criteria: * Age \>= 60 years; * Have a mobile or landline phone; * Self-reported chronic musculoskeletal pain (pain in muscles or joints for \>= 3 months, \>=4 (0-10 scale) average pain level over last week, \>=1 day/previous 30 when pain made it difficult to do usual activities); * Self-reported loneliness (Feeling lonely "some of the time" or more often); * Able to converse comfortably in English. Exclusion Criteria: * Serious acute illness or hospitalization in the last month; * Planned major surgery in the next three months that would interfere with program participation (e.g., knee or hip replacement); * Severe cognitive impairment or other severe physical or psychiatric disorder judged by study team to pose a significant barrier to participation.

Contact & Investigator

Central Contact

Mary R. Janevic, PhD

✉ mjanevic@umich.edu

📞 734-647-3194

Principal Investigator

Cary Reid, MD, PhD

PRINCIPAL INVESTIGATOR

Weill Medical College of Cornell University

Frequently Asked Questions

Who can join the NCT06671925 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06671925 currently recruiting?

Yes, NCT06671925 is actively recruiting participants. Contact the research team at mjanevic@umich.edu for enrollment information.

Where is the NCT06671925 trial being conducted?

This trial is being conducted at Ann Arbor, United States.

Who is sponsoring the NCT06671925 clinical trial?

NCT06671925 is sponsored by Weill Medical College of Cornell University. The principal investigator is Cary Reid, MD, PhD at Weill Medical College of Cornell University. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology